| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,395 |
8,836 |
$588K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,815 |
1,753 |
$89K |
| 99199 |
Unlisted special service, procedure or report |
5,408 |
5,346 |
$20K |
| 80305 |
|
2,197 |
1,636 |
$12K |
| 99215 |
Prolong outpt/office vis |
129 |
108 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
67 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
287 |
189 |
$6K |
| 94375 |
|
1,026 |
959 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
106 |
99 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
352 |
270 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
15 |
15 |
$3K |
| 82962 |
|
2,189 |
1,651 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
200 |
82 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,154 |
1,090 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
128 |
94 |
$1K |
| 95886 |
|
12 |
12 |
$1K |
| 94690 |
|
32 |
27 |
$806.50 |
| 71046 |
Radiologic examination, chest; 2 views |
62 |
50 |
$655.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
51 |
50 |
$551.07 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
62 |
62 |
$437.74 |
| 96103 |
|
34 |
34 |
$124.02 |
| 81003 |
|
86 |
68 |
$100.84 |
| 94618 |
|
26 |
25 |
$95.08 |
| 93000 |
|
15 |
12 |
$89.98 |
| 94060 |
|
12 |
12 |
$82.28 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.27 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
24 |
24 |
$0.15 |
| 3078F |
|
1,012 |
681 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| 3077F |
|
444 |
306 |
$0.00 |
| 1125F |
|
1,261 |
818 |
$0.00 |
| 3074F |
|
1,153 |
801 |
$0.00 |
| 3080F |
|
302 |
229 |
$0.00 |
| 3079F |
|
577 |
414 |
$0.00 |
| 1126F |
|
541 |
401 |
$0.00 |
| 3075F |
|
250 |
182 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
13 |
13 |
$0.00 |
| 90688 |
|
16 |
15 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
29 |
29 |
$0.00 |